Capital Research Global Investors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.45B | Buy |
6,955,345
+2,307,190
| +50% | +$823M | 0.38% | 59 |
|
|
2025
Q4 | $1.52B | Sell |
4,648,155
-83,135
| -2% | -$26.4M | 0.28% | 80 |
|
|
2025
Q3 | $1.34B | Buy |
4,731,290
+122,631
| +3% | +$35.6M | 0.25% | 94 |
|
|
2025
Q2 | $1.29B | Buy |
4,608,659
+90,189
| +2% | +$25.6M | 0.26% | 84 |
|
|
2025
Q1 | $1.41B | Sell |
4,518,470
-371,622
| -8% | -$110M | 0.31% | 76 |
|
|
2024
Q4 | $1.27B | Buy |
4,890,092
+839,686
| +21% | +$249M | 0.26% | 89 |
|
|
2024
Q3 | $1.31B | Buy |
4,050,406
+45,944
| +1% | +$15M | 0.27% | 80 |
|
|
2024
Q2 | $1.25B | Sell |
4,004,462
-1,666,301
| -29% | -$490M | 0.27% | 81 |
|
|
2024
Q1 | $1.61B | Sell |
5,670,763
-1,035,888
| -15% | -$303M | 0.36% | 65 |
|
|
2023
Q4 | $1.93B | Sell |
6,706,651
-1,786,558
| -21% | -$487M | 0.48% | 57 |
|
|
2023
Q3 | $2.28B | Sell |
8,493,209
-1,076,582
| -11% | -$269M | 0.63% | 42 |
|
|
2023
Q2 | $2.12B | Sell |
9,569,791
-2,258,318
| -19% | -$524M | 0.57% | 49 |
|
|
2023
Q1 | $2.86B | Sell |
11,828,109
-89,456
| -0.8% | -$22M | 0.82% | 31 |
|
|
2022
Q4 | $3.13B | Sell |
11,917,565
-687,700
| -5% | -$184M | 0.95% | 25 |
|
|
2022
Q3 | $2.84B | Sell |
12,605,265
-1,490,071
| -11% | -$361M | 0.93% | 22 |
|
|
2022
Q2 | $3.43B | Sell |
14,095,336
-4,336,215
| -24% | -$1.06B | 1.07% | 21 |
|
|
2022
Q1 | $4.46B | Sell |
18,431,551
-3,726,355
| -17% | -$856M | 1.1% | 20 |
|
|
2021
Q4 | $4.98B | Sell |
22,157,906
-4,566,275
| -17% | -$964M | 1.1% | 22 |
|
|
2021
Q3 | $5.68B | Sell |
26,724,181
-2,586,436
| -9% | -$595M | 1.33% | 14 |
|
|
2021
Q2 | $7.14B | Sell |
29,310,617
-3,307,947
| -10% | -$814M | 1.66% | 12 |
|
|
2021
Q1 | $8.12B | Buy |
32,618,564
+856,237
| +3% | +$204M | 1.99% | 8 |
|
|
2020
Q4 | $7.3B | Sell |
31,762,327
-1,738,686
| -5% | -$401M | 1.9% | 8 |
|
|
2020
Q3 | $8.51B | Buy |
33,501,013
+139,339
| +0.4% | +$34.5M | 2.56% | 7 |
|
|
2020
Q2 | $7.87B | Buy |
33,361,674
+251,029
| +0.8% | +$57.3M | 2.49% | 8 |
|
|
2020
Q1 | $6.71B | Sell |
33,110,645
-2,226,994
| -6% | -$486M | 2.63% | 8 |
|
|
2019
Q4 | $8.52B | Buy |
35,337,639
+1,743,084
| +5% | +$384M | 2.55% | 7 |
|
|
2019
Q3 | $6.5B | Buy |
33,594,555
+4,036,798
| +14% | +$775M | 2.13% | 8 |
|
|
2019
Q2 | $5.45B | Sell |
29,557,757
-3,836,745
| -11% | -$687M | 1.73% | 9 |
|
|
2019
Q1 | $6.34B | Sell |
33,394,502
-1,750,473
| -5% | -$334M | 2.01% | 8 |
|
|
2018
Q4 | $6.84B | Buy |
35,144,975
+722,277
| +2% | +$141M | 2.38% | 7 |
|
|
2018
Q3 | $7.14B | Sell |
34,422,698
-11,515,778
| -25% | -$2.27B | 2.07% | 8 |
|
|
2018
Q2 | $8.48B | Sell |
45,938,476
-1,096,159
| -2% | -$194M | 2.32% | 5 |
|
|
2018
Q1 | $8.02B | Sell |
47,034,635
-3,888,105
| -8% | -$714M | 2.28% | 5 |
|
|
2017
Q4 | $8.86B | Sell |
50,922,740
-1,559,732
| -3% | -$276M | 2.6% | 3 |
|
|
2017
Q3 | $9.79B | Sell |
52,482,472
-1,264,494
| -2% | -$224M | 2.95% | 3 |
|
|
2017
Q2 | $9.26B | Sell |
53,746,966
-3,578,169
| -6% | -$582M | 2.9% | 3 |
|
|
2017
Q1 | $9.41B | Sell |
57,325,135
-8,157,032
| -12% | -$1.36B | 2.97% | 3 |
|
|
2016
Q4 | $9.57B | Sell |
65,482,167
-13,429,520
| -17% | -$2.02B | 3.1% | 2 |
|
|
2016
Q3 | $13.2B | Sell |
78,911,687
-3,963,776
| -5% | -$670M | 4.35% | 1 |
|
|
2016
Q2 | $12.6B | Sell |
82,875,463
-6,400,045
| -7% | -$995M | 4.31% | 1 |
|
|
2016
Q1 | $13.4B | Sell |
89,275,508
-2,685,500
| -3% | -$399M | 4.61% | 1 |
|
|
2015
Q4 | $14.9B | Sell |
91,961,008
-1,178,640
| -1% | -$185M | 5.11% | 1 |
|
|
2015
Q3 | $12.9B | Hold |
93,139,648
| – | – | 4.61% | 1 |
|
|
2015
Q2 | $14.3B | Sell |
93,139,648
-42,427
| -0% | -$6.8M | 4.7% | 1 |
|
|
2015
Q1 | $14.9B | Buy |
93,182,075
+15,700
| +0% | +$2.47M | 5.1% | 1 |
|
|
2014
Q4 | $14.8B | Buy |
93,166,375
+137,803
| +0.1% | +$21.5M | 5.04% | 1 |
|
|
2014
Q3 | $13.1B | Buy |
93,028,572
+293,700
| +0.3% | +$38.3M | 4.52% | 1 |
|
|
2014
Q2 | $11B | Buy |
92,734,872
+10,213,473
| +12% | +$1.18B | 3.84% | 2 |
|
|
2014
Q1 | $10.2B | Buy |
82,521,399
+5,088,939
| +7% | +$617M | 3.68% | 1 |
|
|
2013
Q4 | $8.84B | Buy |
77,432,460
+9,832,857
| +15% | +$1.12B | 3.27% | 2 |
|
|
2013
Q3 | $7.57B | Buy |
67,599,603
+540,100
| +0.8% | +$58.6M | 2.99% | 3 |
|
|
2013
Q2 | $6.62B | Buy |
+67,059,503
| New | +$6.96B | 2.81% | 4 |
|
Other funds holding AMGN
VCM
VPM
Capital Research Global Investors's AMGN Position: Q1 2026 in Review
Capital Research Global Investors increased its Amgen (AMGN) stake by 50% in Q1 2026, buying an estimated $823M and bringing the position to 6,955,345 shares worth $2.45B. The position accounts for 0.38% of the portfolio, ranked #59.
Capital Research Global Investors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $14.9B in Q4 2015. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Capital Research Global Investors held 6,955,345 shares of Amgen worth $2.45B as of Q1 2026.
- Capital Research Global Investors bought 2,307,190 Amgen shares in Q1 2026, an estimated $823M.
- Amgen made up 0.38% of Capital Research Global Investors's portfolio in Q1 2026, its #59 holding.
- Capital Research Global Investors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Capital Research Global Investors's Amgen position peaked at $14.9B in Q4 2015.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.